Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.

ethics (see medical ethics) health economics public health quality in health care

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 02 2022
Historique:
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 23 3 2022
Statut: epublish

Résumé

To investigate the financial relationships between key opinion leader (KOL) or non-KOL physicians and pharmaceutical and device companies in France. Retrospective and descriptive study. All doctors practising in France, with a focus on 548 KOLs (board members of the professional medical associations that published guidelines in 2018-2019, identified on the associations' websites between 2018 and 2020). Ties were collected from the 'Transparency in Healthcare' database. The number and the value of gifts from 2014 to 2019, and of remunerations and contractual agreements from 2017 to 2019. KOLs represented 0.24% of the total number of physicians in France. The total value of gifts declared in the French database for all physicians amounted to €818M (US$936M, £741M). At least one gift was declared for 83% of KOLs. KOLs' gifts represented 0.68% of the total number of gifts to physicians and 1.5% of the total value of gifts, with a mean of €3700 per capita per year.The total value of contractual agreements declared for all physicians amounted to €125M. Contractual agreements involving the KOLs represented 0.72% of the number of contractual agreements with physicians and 2.5% of the value of the agreements, with a mean of €1900 per capita per year.A total of €156M in remunerations were declared for all physicians. KOL remunerations represented 2.3% of the number of physician remunerations and 4.4% of the total value of the remunerations paid to physicians, with a mean of €4100 per capita per year.Almost all professional medical associations (99%) had at least one KOL in their board with a financial tie to the industry, but the amount varied widely among the associations. Financial relationships between KOLs and the industry in France are extensive. KOLs have much more financial ties than non-KOL practitioners.

Identifiants

pubmed: 35110312
pii: bmjopen-2021-051042
doi: 10.1136/bmjopen-2021-051042
pmc: PMC8811544
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e051042

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Dtsch Arztebl Int. 2013 Sep;110(35-36):575-83
pubmed: 24078837
JAMA Dermatol. 2017 Dec 1;153(12):1229-1235
pubmed: 29049553
PLoS Med. 2013 Aug;10(8):e1001500
pubmed: 23966841
CMAJ. 2020 Jun 8;192(23):E617-E625
pubmed: 32538799
JAMA Intern Med. 2016 Aug 1;176(8):1114-1122
pubmed: 27322350
Cochrane Database Syst Rev. 2017 Feb 16;2:MR000033
pubmed: 28207928
BMJ. 2020 May 27;369:m1505
pubmed: 32461201
Int J Health Policy Manag. 2018 Mar 14;7(6):504-509
pubmed: 29935127
Rev Epidemiol Sante Publique. 2011 Aug;59(4):233-42
pubmed: 21757308
CMAJ. 2015 Jul 6;:
pubmed: 26149703
Health Serv Res. 2019 Jun;54(3):636-649
pubmed: 30273976
Open Med. 2014 Jan 14;8(1):e10-3
pubmed: 25009680
JAMA Intern Med. 2018 Dec 1;178(12):1711-1712
pubmed: 30383088
Dermatol Ther. 2009 May-Jun;22(3):262-8
pubmed: 19453351
Rev Med Brux. 2010 May-Jun;31(3):199-205
pubmed: 20687450
JAMA Otolaryngol Head Neck Surg. 2018 Mar 1;144(3):194-201
pubmed: 29270633
BMJ. 2008 Jun 21;336(7658):1405
pubmed: 18566076
BMJ. 2019 Dec 3;367:l6576
pubmed: 31796508
BMJ. 2008 Jun 21;336(7658):1402-3
pubmed: 18566074
JAMA Netw Open. 2019 Jan 4;2(1):e186007
pubmed: 30657529
BMJ. 2019 Nov 5;367:l6015
pubmed: 31690553
J Law Med Ethics. 2013 Fall;41(3):635-43
pubmed: 24088154

Auteurs

Marie Clinckemaillie (M)

Département d'Enseignement et de Recherche en Médecine Générale, RETINES, HEALTHY, Université Côte d'Azur, Nice, France.

Alexandre Scanff (A)

CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], Université de Rennes, Rennes, France.

Florian Naudet (F)

Clinical Investigation Center (INSERM 1414) and Adult Psychiatry Department, Rennes University Hospital, Rennes 1 University, Rennes, Bretagne, France.

Adriaan Barbaroux (A)

Département d'Enseignement et de Recherche en Médecine Générale, RETINES, LAPCOS, HEALTHY, Université Côte d'Azur, Nice, France adriaan.barbaroux@univ-cotedazur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH